Protein-specific and shared genetic pathways influence the spread of amyloid-β and tau pathology. Hence, distinct gene expression profiles may induce regional vulnerability of the human cortex to the specific proteinopathies of Alzheimer’s disease.
References
Braak, H. & Braak, E. Acta. Neuropathol. 82, 239–259 (1991).
Thal, D. R., Rüb, U., Orantes, M. & Braak, H. Neurology 58, 1791–1800 (2002).
Palmqvist, S. et al. Nat. Commun. 8, 1214 (2017).
Gordon, B. A. et al. Lancet. Neurol. 17, 241–250 (2018).
Schöll, M. et al. Neuron. 89, 971–982 (2016).
Ossenkoppele, R. et al. JAMA 320, 1151–1162 (2018).
Sepulcre, J. et al. Nature Medicine https://doi.org/10.1038/s41591-018-0206-4 (2018).
Hawrylycz, M. J. et al. Nature 489, 391–399 (2012).
Grothe, M. J. et al. Brain 141, 2755–2771 (2018).
van der Lee, S. J. et al. Lancet. Neurol. 17, 434–444 (2018).
Takahashi, R. H. et al. Am. J. Pathol. 161, 1869–1879 (2002).
Wang, Y. & Mandelkow, E. Nat. Rev. Neurosci. 17, 5–21 (2016).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ossenkoppele, R., Hansson, O. Genetic characterization of amyloid-β and tau network spread . Nat Med 24, 1790–1792 (2018). https://doi.org/10.1038/s41591-018-0277-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-018-0277-2
- Springer Nature America, Inc.
This article is cited by
-
Identification of new BACE1 inhibitors for treating Alzheimer’s disease
Journal of Molecular Modeling (2021)